Overall, urinary sCD14 levels measured by the FRENDTM-CD14 system showed only modest diagnostic performance for assessing RA activity and for predicting treatment outcome, although results correlated with RA activity and showed excellent analytic performance when compared with those obtained using the conventional ELISA method. This evidence concerns the gene CD14 and rheumatoid arthritis.